Form 8-K MACROGENICS INC For: Jun 30
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/9/2026
- S&P 500 ends down after Trump says Iran deal is 'over'
- Oil settles at multi-week high as US-Iran truce buckles under fresh hostilities
- Nvidia is up just 3% YTD while SOX surges 82% — what’s holding it back?
- BofA says S&P 500 technicals point to corrective Q3
- Alibaba rallies 12% after report of narrowing losses sparks pre-earnings optimism
- Morgan Stanley Reiterates Overweight Rating on Rocket Lab USA (RKLB), Bull Case Raised to $293
- Crude Inventory Rose 3 Million Barrels Last Week - EIA
- GameStop stockholders approve share count increase to 2.5 billion
- AI bubble fears mount as Zuckerberg admits agent delays and Burry shorts sector
- S&P 500 ends down after Trump says Iran deal is 'over'
MacroGenics sells CDMO operations to Bora Pharmaceuticals for $122.5M
July 7, 2026 4:34 PM EDTMacroGenics, Inc. (NASDAQ: MGNX) completed the sale of its contract development and manufacturing organization (CDMO) operations to Bora Pharmaceuticals Co., Ltd. and Bora Biologics USA, LLC on June 30, 2026.
The transaction, originally announced via an Asset Purchase Agreement dated May 11, 2026, involved the transfer of... More
